Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03833050 · ClinicalTrials.gov registry record
The TOGETHER Project - Heart
A clinical trial of Heart Transplant Rejection, sponsored by Mayo Clinic.
- Completed
- Registry status
- 101
- Enrollment target
- 3
- Study locations
NCT03833050 is a study of Heart Transplant Rejection that has completed, run by Mayo Clinic. The registered enrollment target is 101 participants, below the 721-participant average among 5 other Heart Transplant Rejection trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT03833050, a study of Heart Transplant Rejection, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
- 3
- Study locations
Study Summary
The researchers are trying to develop a way to measure the risk of transplant rejection with a blood test.
Conditions Studied
Study Locations (3)
Arizona
- Mayo Clinic - Phoenix
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2017-12-07 |
| Est. Completion | 2020-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03833050
The ClinicalTrials.gov registry entry for NCT03833050 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 721-participant average among 5 other Heart Transplant Rejection trials with a reported enrollment target (86% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Transplant Rejection appearing as the primary indexed condition, and to 0 interventions.
NCT03833050 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03833050 about?
NCT03833050 is a clinical study titled "The TOGETHER Project - Heart". The researchers are trying to develop a way to measure the risk of transplant rejection with a blood test.
What is the current status of trial NCT03833050?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2017-12-07. Estimated completion is 2020-09-22.
What conditions does trial NCT03833050 study?
This clinical trial studies the following conditions: Heart Transplant Rejection.
Who is sponsoring clinical trial NCT03833050?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03833050 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Transplant Rejection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Trifecta-Heart cfDNA-MMDx Study
RECRUITING
-
Prospera Test Evaluation in Cardiac Transplant (ProTECT)
ACTIVE NOT RECRUITING
-
Surveillance HeartCare® Outcomes Registry
ACTIVE NOT RECRUITING
-
Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.